SWLA1 (ATCC® HB-12559)

Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)  /  Cell Type: hybridoma: B lymphocyte  / 

Permits and Restrictions

View Permits

Organism Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type hybridoma: B lymphocyte
Product Format frozen
Morphology lymphoblast
Culture Properties suspension
Biosafety Level 1
Strain

Strain: BALB/c (B cell); BALB/c (myeloma)

Applications
The SWLA1 (ATCC HB-12559), SWLA2 (ATCC HB-12580), and SWLA3 (ATCC HB-12558) antibodies appear to recognize a species-specific lipooligosaccharide or lipopolysaccharide on the cell surface of S. mutans.
These antibodies can be used in the clinical diagnosis and treatment of dental caries in humans.
Derivation
Spleen cells were fused with NS-1-Ag4-1 myeloma cells.
Genes Expressed
immunoglobulin; monoclonal antibody; against Streptococcus mutans
Cellular Products
immunoglobulin; monoclonal antibody; against Streptococcus mutans
Comments
Animals were immunized with Streptococcus mutans Clarke (ATCC 25175).
Spleen cells were fused with NS-1-Ag4-1 myeloma cells.
The SWLA1 (ATCC HB-12559), SWLA2 (ATCC HB-12580), and SWLA3 (ATCC HB-12558) antibodies appear to recognize a species-specific lipooligosaccharide or lipopolysaccharide on the cell surface of S. mutans.
These antibodies have substantially no reactivity with any of the following bacterial strains: Streptococcus rattus (ATCC 19645, Streptococcus gordonii (ATCC 10558), Streptococcus gordonii (ATCC 13396), Streptococcus mitis (ATCC 49456).
Also Streptococcus sobrinus (ATCC 33478), Streptococcus sobrinus 6715, Streptococcus sanguis (ATCC 10556), Streptococcus sanguis (ATCC 49295), Streptococcus anginosus (ATCC 33397), Lactobacillus acidophilus (ATCC 4356), Lactobacillus casei (ATCC 4646),
Actinobacillus actinomycetemcomitans (ATCC 33384), Porphyromonas gingivalis (ATCC 33277), Prevotella intermedia (ATCC 49046), Bacteroides forsythus (ATCC 43047), Eikenella corrodens (ATCC 23834), Fusobacterium nucleatum (ATCC 25586),
Treponema denticola (ATCC 33520), Campylobacter rectus (ATCC 33238), Myxococcus xanthus DZ2, and Escherichia coli HB101.
These antibodies can be used in the clinical diagnosis and treatment of dental caries in humans.
Complete Growth Medium HL-1 medium supplemented with 4 mM L-glutamine, 1 mM sodium pyruvate and 10% fetal bovine serum. HL-1 medium can be obtained from from Lonza (catalog number 77201).
Subculturing
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 X 10 exp5 viable cells/ml.
Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
Cryopreservation
culture medium 95%; DMSO, 5%
Culture Conditions
Temperature: 37.0°C
Isotype IgG2a; kappa light chain
Name of Depositor Regents of the University of California
References

Shi W, Hume WR. Antibodies to S. mutans and uses thereof. US Patent 6,231,857 dated May 15 2001

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
References

Shi W, Hume WR. Antibodies to S. mutans and uses thereof. US Patent 6,231,857 dated May 15 2001